Lixte Biotechnology Holdings, Inc. (LIXT) Financial Statements (2024 and earlier)

Company Profile

Business Address 248 ROUTE 25A
EAST SETAUKET, NY 11733
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments5,353,3924,823,7455,069,2662,598,8644,273,0121,305,748
Cash and cash equivalents5,353,3924,823,7455,069,2662,598,8644,273,0121,305,748
Receivables    14,367  
Prepaid expense49,224109,02967,311 9,175 
Contract with customer, asset, after allowance for credit loss   76,898  
Other undisclosed current assets157,397160,49015,00058,80252,25862,317
Total current assets:5,560,0135,093,2645,228,4752,672,0334,334,4451,368,065
Noncurrent Assets
Prepaid expense     2,293 
Total noncurrent assets:     2,293 
TOTAL ASSETS:5,560,0135,093,2645,228,4752,672,0334,336,7381,368,065
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:229,764225,965190,292143,549195,211312,034
Other undisclosed accounts payable and accrued liabilities229,764225,965190,292143,549195,211312,034
Deferred revenue   15,765 
Due to related parties46,98232,500    
Other undisclosed current liabilities118,04044,46110,46794,34915,70460,990
Total current liabilities:394,786302,926216,524237,898210,915373,024
Noncurrent Liabilities
Total liabilities:394,786302,926216,524237,898210,915373,024
Equity
Equity, attributable to parent5,165,2274,790,3385,011,9512,434,1354,125,823995,041
Preferred stock3,500,0003,500,0003,500,0003,500,0003,500,0003,500,000
Common stock1,6641,3741,2406,7046,7045,802
Additional paid in capital45,058,26238,371,12831,864,47926,016,31725,267,66220,004,654
Accumulated deficit(43,394,699)(37,082,164)(30,353,768)(27,088,886)(24,648,543)(22,515,415)
Total equity:5,165,2274,790,3385,011,9512,434,1354,125,823995,041
TOTAL LIABILITIES AND EQUITY:5,560,0135,093,2645,228,4752,672,0334,336,7381,368,065

Income Statement (P&L) (USD)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Cost of goods and services sold(2,547,615)(3,024,114)    
Gross profit:(2,547,615)(3,024,114)    
Operating expenses(6,311,481)(6,720,445)(3,266,440)(2,490,066)(2,138,051)(1,809,789)
Other undisclosed operating income2,547,6153,024,114    
Operating loss:(6,311,481)(6,720,445)(3,266,440)(2,490,066)(2,138,051)(1,809,789)
Nonoperating income (expense)7,821(537)5,23249,7234,9231,375
Investment income, nonoperating11,1956265,23249,7234,9231,375
Gain (loss), foreign currency transaction, before tax(3,374)(1,163)    
Interest and debt expense(8,875)(7,414)(3,674)   
Loss from continuing operations:(6,312,535)(6,728,396)(3,264,882)(2,440,343)(2,133,128)(1,808,414)
Loss before gain (loss) on sale of properties:(6,728,396)(3,264,882)(2,440,343)(2,133,128)(1,808,414)
Net loss available to common stockholders, diluted:(6,312,535)(6,728,396)(3,264,882)(2,440,343)(2,133,128)(1,808,414)

Comprehensive Income (USD)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(6,312,535)(6,728,396)(3,264,882)(2,440,343)(2,133,128)(1,808,414)
Comprehensive loss, net of tax, attributable to parent:(6,312,535)(6,728,396)(3,264,882)(2,440,343)(2,133,128)(1,808,414)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: